Chemical activators of DEPDC4 include a range of compounds that can initiate a series of biochemical events leading to the protein's activation. Forskolin is a well-known diterpene that directly stimulates adenylyl cyclase, which in turn boosts intracellular cAMP levels. The increase in cAMP activates protein kinase A (PKA), a kinase that can phosphorylate DEPDC4, resulting in its activation. Similarly, 8-Bromo-cyclic AMP, a cAMP analog, engages the same pathway: it activates PKA, which then targets DEPDC4 for phosphorylation, triggering its activation. Phorbol 12-myristate 13-acetate (PMA), another potent biologically active compound, activates protein kinase C (PKC). PKC is implicated in a multitude of signaling cascades and can directly phosphorylate DEPDC4, leading to the protein's functional activation. Ionomycin, a calcium ionophore, escalates intracellular calcium levels and thus can activate calcium-dependent protein kinases that may phosphorylate and activate DEPDC4.
Continuing with the theme of phosphorylation as a means of activation, Sodium orthovanadate serves as an inhibitor of protein tyrosine phosphatases. This action prevents the dephosphorylation of proteins, potentially maintaining DEPDC4 in an active phosphorylated state. Epidermal Growth Factor (EGF) engages its receptor, setting off a phosphorylation cascade that can encompass the phosphorylation and subsequent activation of DEPDC4. In addition, 3-Isobutyl-1-methylxanthine (IBMX) inhibits phosphodiesterases, which leads to elevated cAMP levels and subsequent PKA activation. PKA then can phosphorylate DEPDC4, thus promoting its activation. The presence of oxidative stress, as represented by Hydrogen peroxide, induces oxidative modifications in proteins. These modifications can alter the structural conformation of DEPDC4, leading to its activation. Furthermore, Thapsigargin, by disrupting calcium stores, can activate calcium-dependent kinases, which can then phosphorylate and activate DEPDC4. Lastly, metal ions such as those provided by Zinc acetate and Magnesium sulfate can bind to DEPDC4 or act as co-factors, respectively, ensuring the protein assumes the correct conformation for its enzymatic activity or facilitating the interaction with other proteins or substrates required for DEPDC4 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC which is known to phosphorylate various proteins. PKC-mediated phosphorylation of DEPDC4 would result in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium-dependent protein kinases. These kinases can phosphorylate DEPDC4, leading to its activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
This cAMP analog activates PKA. PKA can then phosphorylate DEPDC4, resulting in activation of the protein. | ||||||
Penicillamine | 52-67-5 | sc-205795 sc-205795A | 1 g 5 g | $46.00 $96.00 | ||
SNAP donates nitric oxide, which can lead to the S-nitrosylation of cysteine residues on proteins. S-nitrosylation can activate DEPDC4 by inducing conformational changes that enhance its activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can bind to specific sites on DEPDC4, potentially causing allosteric activation of the protein. | ||||||
Magnesium sulfate anhydrous | 7487-88-9 | sc-211764 sc-211764A sc-211764B sc-211764C sc-211764D | 500 g 1 kg 2.5 kg 5 kg 10 kg | $46.00 $69.00 $163.00 $245.00 $418.00 | 3 | |
Magnesium ions can act as enzymatic cofactors, which may include cofactor roles in the activation of DEPDC4 by ensuring proper conformation for its activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate inhibits protein tyrosine phosphatases, which could prevent the dephosphorylation of DEPDC4, thereby maintaining it in a phosphorylated and active state. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide can induce oxidative modifications of cysteine residues on proteins. Such modifications on DEPDC4 can lead to its activation through structural changes or through affecting its interaction with other cellular components. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
By disrupting calcium stores and increasing cytosolic calcium, thapsigargin can activate calcium-dependent kinases that may phosphorylate and activate DEPDC4. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to increased cAMP levels, which then activate PKA. PKA is capable of phosphorylating DEPDC4, which would lead to its activation. | ||||||